Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medios AGMEDOF 88 Days Sales Outstanding is 28.60 as of Jun. 2026, which is 22% above its 10-year median of 23.40. GuruFocus rates MEDOF with a GF Score™ of 88/100 and a GF Value™ of $78.64. The stock has 2 warning signs investors should review. Among 118 Medical Distribution companies, Medios AG ranks better than 93.22% on this metric.
Medios AG's average Accounts Receivable for the
three
months ended in Jun. 2026 was $198 Mil. Medios AG's Revenue for the
three
months ended in Jun. 2026 was $631 Mil.
Hence, Medios AG's Days Sales Outstanding for the
three
months ended in Jun. 2026 was 28.60.
The historical rank and industry rank for Medios AG's Days Sales Outstanding or its related term are showing as below:
MEDOF'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 21.86 Med: 23.4 Max: 34.25
Current: 27.12
During the past 13 years, Medios AG's highest Days Sales Outstanding was 34.25. The lowest was 21.86. And the median was 23.40.
MEDOF's Days Sales Outstanding is ranked better than 93.22% of 118
companies
in the Medical Distribution industry
Industry Median: 74.915
vs MEDOF: 27.12
Medios AG's Days Sales Outstanding
increased
from Jun. 2025 (26.29) to Jun. 2026 (28.60).
Medios AG (OTCPK:MEDOF) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Medios AG Days Sales Outstanding Related Terms
Medios AG Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for Medios AG's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEDOF vs MCK, COR, CAH: Days Sales Outstanding Comparison
For the Medical Distribution subindustry, Medios AG's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medios AG Days Sales Outstanding vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Medios AG's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Medios AG's Days Sales Outstanding falls into.
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medios AG (MEDOF) has a Days Sales Outstanding of 28.60 as of Jun. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Medios AG and its competitors. This is 22% above median its historical median of 23.40. Over the past decade, Medios AG's Days Sales Outstanding has ranged from 21.86 to 34.25. According to the industry distribution chart, Medios AG ranks #8 out of 118 companies in the Medical Distribution industry, placing it in the top 6.8%.
Is Medios AG's Days Sales Outstanding too high?
Medios AG's current Days Sales Outstanding of 28.60 is 22% above median its 10-year median of 23.40. Over the past 10 years, this metric has ranged from a low of 21.86 to a high of 34.25. The Medical Distribution industry median Days Sales Outstanding is 74.92. Medios AG's value of 28.60 is 61.8% below this industry median. Based on the distribution chart, Medios AG ranks #8 out of 118 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Medios AG has a GF Score™ of 88/100, reflecting its overall financial health beyond just this single metric.
How does Medios AG's Days Sales Outstanding compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Medios AG ranks #8 out of 118 companies for Days Sales Outstanding. This places Medios AG in the top 7% of its industry — outperforming the majority of peers. The industry median Days Sales Outstanding is 74.92. Medios AG's value of 28.60 is 61.8% below this benchmark. Historically, Medios AG's own Days Sales Outstanding has ranged from 21.86 to 34.25 over the past decade. While the company's 10-year median is 23.40 vs. the industry median of 74.92, Medios AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Medical Distribution company?
The median Days Sales Outstanding among Medical Distribution companies is 74.92, based on 118 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medios AG's current Days Sales Outstanding of 28.60 is 61.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Medios AG and its competitors. For the Medical Distribution industry, the median Days Sales Outstanding is 74.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medios AG's current Days Sales Outstanding is 28.60, which is 22% above median its own 10-year median of 23.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medios AG stock overvalued right now?
Medios AG (MEDOF) has a current Days Sales Outstanding of 28.60. The stock's GF Value™ is $78.64, compared to a current price of $50.00 — trading 36.4% below its estimated fair value. The current Days Sales Outstanding is 28.60, which is 22% above median its 10-year median of 23.40 and 61.8% below the Medical Distribution industry median of 74.92. Medios AG's overall GF Score™ is 88/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Medios AG (MEDOF), the current Days Sales Outstanding is 28.60 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medios AG (MEDOF) Overvalued in 2026?
Based on GuruFocus' analysis, Medios AG stock appears to be undervalued.
The current stock price of $50.00 is trading 36.4% below its estimated GF Value™ of $78.64.
Key valuation signals for MEDOF:
Days Sales Outstanding: 28.60 (22% above median its 10-year median of 23.40)
GF Value™: $78.64 vs. price of $50.00 (36.4% below fair value)
Industry Position: 61.8% below the Medical Distribution median (#8 of 118)
No single metric tells the full story. See the MEDOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medios AG is engaged as a wholesaler for pharmaceutical medicinal products. The operating segments of the company includes: Patient-Specific Therapies: This area includes the compounding of medications on behalf of pharmacies in Germany. Pharmaceautical Supply: Medios is speciality pharma supplier company in germany, producing it own production facilities, hospitals, and Pharmacies. International Business: It includes all business and activities happening in international business.
88GF Score
Get the complete analysis for MEDOF
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEDOF has been successfully added to your 
